Absci Investor Presentation Deck

ABSCI'S END-TO-END PLATFORM SOLUTION The leading full-stack Al platform for biologics drug creation Find patient cohort specific targets ↓ Novel target discovery ai. ABSCI CORPORATION 2023 ALL RIGHTS RESERVED Discover novel antibodies for selected target De novo discovery in silico ai. Optimize antibodies' characteristics 1. Lead optimization in silico p ai. Incorporate site-specific chemical handles Bionic SoluPro™ strain OPTIMAL DRUG CANDIDATE absci. 10

View entire presentation